California Nanotechnologies Corp.
CNO.V
TSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -78.27% | -48.76% | -59.02% | 16.73% | 55.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -78.27% | -48.76% | -59.02% | 16.73% | 55.81% |
| Cost of Revenue | -21.04% | 10.89% | -48.43% | 41.11% | 10.04% |
| Gross Profit | -95.54% | -61.52% | -64.55% | 8.39% | 78.18% |
| SG&A Expenses | 14.19% | 20.66% | 47.92% | 45.39% | 50.65% |
| Depreciation & Amortization | 14.28% | 46.61% | 50.30% | 421.64% | 320.27% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.87% | 21.16% | -1.68% | 58.29% | 43.90% |
| Operating Income | -235.50% | -159.71% | -171.73% | -23,982.35% | 86.03% |
| Income Before Tax | -1,064.28% | 55.30% | -164.35% | 62.22% | -77.96% |
| Income Tax Expenses | -- | -- | -- | 18,777.78% | -- |
| Earnings from Continuing Operations | -1,067.90% | 55.36% | -164.35% | 18.07% | -77.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,067.90% | 55.36% | -164.35% | 18.07% | -77.99% |
| EBIT | -235.50% | -159.71% | -171.73% | -23,982.35% | 86.03% |
| EBITDA | -209.74% | -143.17% | -155.00% | -1,433.47% | 85.78% |
| EPS Basic | -1,020.00% | 57.82% | -161.15% | 25.27% | -83.97% |
| Normalized Basic EPS | -993.75% | 58.51% | -161.22% | 64.91% | -83.51% |
| EPS Diluted | -1,145.45% | 57.82% | -196.00% | 25.27% | -78.00% |
| Normalized Diluted EPS | -1,121.43% | 56.79% | -158.24% | 64.91% | -84.62% |
| Average Basic Shares Outstanding | 6.00% | 5.45% | 5.50% | 9.01% | 36.16% |
| Average Diluted Shares Outstanding | -7.66% | 0.25% | 9.95% | 9.01% | 46.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |